Testosterone Therapy Is Surging: What the TRAVERSE Trial Says About Heart Risk
Testosterone prescriptions are climbing as the 2023 TRAVERSE trial cleared major cardiac fears. Here is what the evidence shows, who benefits, and the real remaining risks.
Marcus Lindqvist, PharmD Aug 21, 2026 4 min read